SIRT5 and Alzheimer disease: Given the diminished levels of SIRT5 in various neurodegenerative disorders and the beneficial restorative effects observed upon the reintroduction of SIRT5 in both our research and other studies, there is growing interest in the targeting of SIRT5 as a therapeutic strategy for Cd‐induced AD‐like pathology.